Navigating Office Dynamics in the Management of Geographic Atrophy

A proactive and patient-centered approach to managing GA

By: Mona Camacci, MD, MS

Retinal Physician January 8, 2025

5 Key Takeaways

1

The management of geographic atrophy (GA) has evolved to prioritize early diagnosis and intervention for better patient outcomes.
2

Advanced imaging techniques like fundus autofluorescence and optical coherence tomography are essential for monitoring GA progression.
3

Since 2023, two FDA-approved medications for GA have improved treatment options, allowing patients to thrive.
4

Safety considerations, including risks of retinal vasculitis and inflammation, are critical in planning GA therapy.
5

Transparent communication with patients about disease progression and treatment expectations is vital for effective GA management.

Mona Camacci, MD, MS

Bio: Mona Camacci, MD, MS, writes on retinal disease management, including geographic atrophy. In Retinal Physician, she has discussed early identification of geographic atrophy, use of fundus autofluorescence and optical coherence tomography to monitor progression, and patient-centered initiation of newly FDA-approved therapies while addressing safety considerations such as retinal vasculitis, inflammation, choroidal neovascularization, and endophthalmitis.

PentaVision

Retinal Physician

Navigating Office Dynamics in the Management of Geographic Atrophy

5 Key Takeaways

1

2

3

4

5

Recommendations